10 Jan Malawi malaria vaccine trial enters last phase
Posted at 14:06h in News
The last phase trial of the world’s most clinically advanced malaria vaccine candidate, known as RTS, is underway at one of the 11 sites in Lilongwe, Malawi.
This investigational vaccine iss administered at UNC Project-Malawi under the auspices of the Institute for Global Health & Infectious Diseases at UNC.
UNC is optimistic that it will complete the recruitment exercise by end of March 2011.